Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 93-99

  Gao, Zhongxiuzi ^a,b   Zheng, Jinhua ^a,b   Yang, Bin ^a   Wang, Zhu ^a   Fan, Haixia ^b   Lv, Yanhong ^b   Li, Haixia ^b   Jia, Limin ^b   Cao, Wenwu ^a,c  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

5 Aminolevulinic acid; Anti angiogenesis; Anti tumor; Sonodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SONODYNAMIC THERAPY; TUBE FORMATION; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER;

AMINOLEVULINIC ACID; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICROVESSELS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RADIATION-SENSITIZING AGENTS; SONICATION; SOUND; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84878446775     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.006     Document Type: Article

References (46)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
3. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 1992, 3:65-71.
4. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002, 29:15-18.
5. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 2004, 11:349-363.
6. Shibaguchi H., Tsuru H., Kuroki M. Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res. 2011, 31:2425-2429.
7. Umemura S., Yumita N., Nishigaki R., Umemura K. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn. J. Cancer Res. 1990, 81:962-966.
8. Liu Q., Wang X., Wang P., Xiao L. Sonodynamic antitumor effect of protoporphyrin IX disodium salt on S180 solid tumor. Chemotherapy 2007, 53:429-436.
9. Liu Q., Li X., Xiao L., Wang P., Wang X., Tang W. Sonodynamically induced antitumor effect of hematoporphyrin on Hepatoma 22. Ultrason. Sonochem. 2008, 15:943-948.
10. Komori C., Okada K., Kawamura K., Chida S., Suzuki T. The sonodynamic antitumor effect of methylene blue on sarcoma180 cells in vitro. Anticancer Res. 2009, 29:2411-2415.
11. Wang X., Wang Y., Wang P., Cheng X., Liu Q. Sonodynamically induced anti-tumor effect with protoporphyrin IX on hepatoma-22 solid tumor. Ultrasonics 2011, 51:539-546.
12. Yumita N., Iwase Y., Nishi K., Ikeda T., Komatsu H., Fukai T., Onodera K., Nishi H., Takeda K., Umemura S., Okudaira K., Momose Y. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6). Anticancer Res. 2011, 31:501-506.
13. Wang X.B., Liu Q.H., Mi N., Wang P., Tang W., Zhao X.H., Li X.J. Sonodynamically induced apoptosis by protoporphyrin IX on hepatoma-22 cells in vitro. Ultrasound Med. Biol. 2010, 36:667-676.
14. Song W., Cui H., Zhang R., Zheng J., Cao W. Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res. 2011, 31:39-45.
15. Xiang J., Xia X., Jiang Y., Leung A.W., Wang X., Xu J., Wang P., Yu H., Bai D., Xu C. Apoptosis of ovarian cancer cells induced by methylene blue-mediated sonodynamic action. Ultrasonics 2011, 51:390-395.
16. Li Y., Wang P., Zhao P., Zhu S., Wang X., Liu Q. Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells. Ultrasonics 2012, 52:490-496.
17. Wang X., Leung A.W., Jiang Y., Yu H., Li X., Xu C. Hypocrellin B-mediated sonodynamic action induces apoptosis of hepatocellular carcinoma cells. Ultrasonics 2012, 52:543-546.
18. Wang X., Liu Q., Wang Z., Wang P., Zhao P., Zhao X., Yang L., Li Y. Role of autophagy in sonodynamic therapy-induced cytotoxicity in S180 cells. Ultrasound Med. Biol. 2010, 36:1933-1946.
19. Zhao P., Liu Q., Wang P., Li T., Wang X., Su S., Zhang M. Autophagic and apoptotic response to sonodynamic therapy induced cell damage in leukemia l1210 cells in vitro. Cancer Biother. Radiopharm. 2011, 26:209-218.
20. Wang X., Wang P., Tong W., Liu Q. Comparison of pharmacokinetics, intracellular localizations and sonodynamic efficacy of endogenous and exogenous protoporphyrin IX in sarcoma 180 cells. Ultrasonics 2010, 50:803-810.
21. Johansson A., Palte G., Schnell O., Tonn J.C., Herms J., Stepp H. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors. Photochem. Photobiol. 2010, 86:1373-1378.
22. Millon S.R., Ostrander J.H., Yazdanfar S., Brown J.Q., Bender J.E., Rajeha A., Ramanujam N. Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes. J. Biomed. Opt. 2010, 15:018002.
23. Hefti M., Albert I., Luginbuehl V. Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells. J. Neurooncol. 2012, 108:443-450.
24. Yamamoto J., Ogura S., Tanaka T., Kitagawa T., Nakano Y., Saito T., Takahashi M., Akiba D., Nishizawa S. Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in glioma cells in vitro. Oncol. Rep. 2012, 27:1748-1752.
25. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2002, 2:795-803.
26. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
27. Ota H., Matsumura M., Miki N., Minamitami H. Photochemically induced increase in endothelial permeability regulated by RhoA activation. Photochem. Photobiol. Sci. 2009, 8:1401-1407.
28. Rodriguez L., de Bruijn H.S., Di Venosa G., Mamone L., Robinson D.J., Juarranz A., Batlle A., Casas A. Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy. J. Photochem. Photobiol. B 2009, 96:249-254.
29. Sporri S., Chopra V., Egger N., Hawkins H.K., Motamedi M., Dreher E., Schneider H. Effects of 5-aminolaevulinic acid on human ovarian cancer cells and human vascular endothelial cells in vitro. J. Photochem. Photobiol. B 2001, 64:8-20.
30. Wyld L., Burn J.L., Reed M.W., Brown N.J. Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br. J. Cancer 1997, 76:705-712.
31. Barzelai S., Sharabani-Yosef O., Holbova R., Castel D., Walden R., Engelberg S., Scheinowitz M. Low-intensity ultrasound induces angiogenesis in rat hind-limb ischemia. Ultrasound Med. Biol. 2006, 32:139-145.
32. Cheung W.H., Chow S.K., Sun M.H., Qin L., Leung K.S. Low-intensity pulsed ultrasound accelerated callus formation, angiogenesis and callus remodeling in osteoporotic fracture healing. Ultrasound Med. Biol. 2011, 37:231-238.
33. Mizrahi N., Seliktar D., Kimmel E. Ultrasound-induced angiogenic response in endothelial cells. Ultrasound Med. Biol. 2007, 33:1818-1829.
34. Ramli R., Reher P., Harris M., Meghji S. The effect of ultrasound on angiogenesis: an in vivo study using the chick chorioallantoic membrane. Int. J. Oral Maxillofac. Implants 2009, 24:591-596.
35. Reher P., Doan N., Bradnock B., Meghji S., Harris M. Effect of ultrasound on the production of IL-8, basic FGF and VEGF. Cytokine 1999, 11:416-423.
36. Altland O.D., Dalecki D., Suchkova V.N., Francis C.W. Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis. J. Thromb. Haemost. 2004, 2:637-643.
37. Choijamts B., Naganuma Y., Nakajima K., Kawarabayashi T., Miyamoto S., Tachibana K., Emoto M. Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft. Cancer Sci. 2011, 102:452-459.
38. Ichikawa K., Takeuchi Y., Yonezawa S., Hikita T., Kurohane K., Namba Y., Oku N. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Cancer Lett. 2004, 205:39-48.
39. Chen B., Pogue B.W., Zhou X., O'Hara J.A., Solban N., Demidenko E., Hoopes P.J., Hasan T. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin. Cancer Res. 2005, 11:720-727.
40. Lim D.S., Ko S.H., Lee C.H., Ahn W.S., Lee W.Y. DH-I-180-3-mediated photodynamic therapy: biodistribution and tumor vascular damage. Photochem. Photobiol. 2006, 82:600-605.
41. Osaki T., Takagi S., Hoshino Y., Okumura M., Fujinaga T. Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models. Cancer Lett. 2007, 248:47-57.
42. Bhuvaneswari R., Gan Y.Y., Lucky S.S., Chin W.W., Ali S.M., Soo K.C., Olivo M. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy. Mol. Cancer 2008, 7:56.
43. Lv Y., Fang M., Zheng J., Yang B., Li H., Xiuzigao Z., Song W., Chen Y., Cao W. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol. Biochem. 2012, 30:321-333.
44. Henderson B.W., Vaughan L., Bellnier D.A., van Leengoed H., Johnson P.G., Oseroff A.R. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem. Photobiol. 1995, 62:780-789.
45. Peng Q., Warloe T., Moan J., Godal A., Apricena F., Giercksky K.E., Nesland J.M. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res. 2001, 61:5824-5832.
46. Brieger K., Schiavone S., Miller F.J., Krause K.H. Reactive oxygen species: from health to disease. Swiss Med. Wkly. 2012, 142:w13659.